Rentokil Initial PLC $RTO Shares Sold by Optiver Holding B.V.

Optiver Holding B.V. cut its holdings in shares of Rentokil Initial PLC (NYSE:RTO) by 89.4% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 51,093 shares of the company’s stock after selling 430,851 shares during the quarter. Optiver Holding B.V.’s holdings in Rentokil Initial were worth $1,608,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd boosted its stake in Rentokil Initial by 222.2% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,163 shares of the company’s stock worth $34,000 after buying an additional 802 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Rentokil Initial during the 4th quarter valued at about $39,000. V Square Quantitative Management LLC increased its stake in shares of Rentokil Initial by 84.5% during the 1st quarter. V Square Quantitative Management LLC now owns 1,395 shares of the company’s stock valued at $44,000 after acquiring an additional 639 shares during the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Rentokil Initial by 296.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,954 shares of the company’s stock worth $58,000 after acquiring an additional 1,461 shares during the period. Finally, IFP Advisors Inc lifted its holdings in shares of Rentokil Initial by 53.8% during the 3rd quarter. IFP Advisors Inc now owns 1,972 shares of the company’s stock worth $50,000 after acquiring an additional 690 shares during the period. 9.91% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on RTO. Zacks Research cut shares of Rentokil Initial from a “hold” rating to a “strong sell” rating in a research report on Monday, June 15th. BNP Paribas Exane downgraded shares of Rentokil Initial from an “outperform” rating to a “neutral” rating and set a $26.70 price target on the stock. in a research note on Friday. The Goldman Sachs Group raised shares of Rentokil Initial from a “neutral” rating to a “buy” rating in a research note on Monday, July 6th. Weiss Ratings reiterated a “hold (c)” rating on shares of Rentokil Initial in a report on Wednesday, June 24th. Finally, Wall Street Zen cut shares of Rentokil Initial from a “buy” rating to a “hold” rating in a research note on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.90.

Rentokil Initial Price Performance

Rentokil Initial stock opened at $23.36 on Friday. The stock’s 50-day moving average is $29.45 and its 200-day moving average is $31.21. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.07 and a current ratio of 1.16. Rentokil Initial PLC has a 12 month low of $23.25 and a 12 month high of $34.67.

Rentokil Initial Cuts Dividend

The firm also recently announced a dividend, which will be paid on Tuesday, September 22nd. Investors of record on Friday, August 14th will be given a dividend of $0.224 per share. This represents a yield of 192.0%. The ex-dividend date of this dividend is Friday, August 14th.

Trending Headlines about Rentokil Initial

Here are the key news stories impacting Rentokil Initial this week:

• Positive Sentiment: Rentokil declared a dividend of $0.224 per share for shareholders of record on August 14, payable September 22. The distribution provides ongoing shareholder income, although the reported dividend-yield figure appears inconsistent with the payment amount and should be verified. Rentokil dividend information
• Positive Sentiment: Stifel said the sell-off may have been excessive because adjusted first-half pretax profit of $459 million exceeded consensus by 4%. That suggests the underlying results were stronger than the market reaction implied, despite concerns about North America. Rentokil sell-off may be overdone
• Neutral Sentiment: The company’s second-quarter earnings presentation and conference-call transcript provide additional detail on performance, cost management and its outlook, but do not by themselves change the main investor concern around North American demand. Rentokil 2026 second-quarter results presentation Rentokil 2026 second-quarter earnings call transcript
• Negative Sentiment: Management warned that residential customer leads in North America softened late in the second quarter and into July. Because North America is a key growth and profit driver, the demand slowdown raises concerns about near-term revenue growth and operating leverage. Rentokil North American demand warning
• Negative Sentiment: Rentokil abandoned a key North American margin target, intensifying concerns that weaker demand could pressure profitability and delay its recovery plan. MarketBeat also reported quarterly EPS of $0.34, below its $0.66 consensus estimate, contributing to the negative reaction. Rentokil quarterly earnings report

Rentokil Initial Company Profile

Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.

Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.